Work

Abstract 1381: BCL-2 selective inhibitor venetoclax combined with topoisomerase I inhibitor irinotecan is effective in small cell lung cancer (SCLC)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1381

Authors: Yanli Xing, Krista M. Dalton, Jane L. Roberts, Anthony C. Faber

Institution: Virginia Commonwealth University

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631013

Cites:

Cited by:

Related to: 10